Should we implement ‘opt-out’ HIV testing for patients with lymphoma?

Author： Cave J   Edwards SG   Miller RF   Ardeshna KM   Lee SM  

Publisher： Royal College Of Physicians

ISSN： 1470-2118

Source： Clinical Medicine, Vol.9, Iss.4, 2009-08, pp. : 320-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV in IDUs: should we bother?

By Panda S.  

The International Journal of Drug Policy, Vol. 14, Iss. 1, 2003-02 ,pp. : 83-85

Elsevier

Access to resources Recommend Favorite

How should we “empower” cancer patients?

By Kaur Judith S.  

Cancer, Vol. 120, Iss. 20, 2014-10 ,pp. : 3108-3110

Blackwell Publishing

Access to resources Recommend Favorite

Should we recommend the therapeutical use of vitamin E in diabetic patients?

By Paolisso G.   Barbieri M.   Rosaria Rizzo M.   Manzella D.  

Environmental Toxicology and Pharmacology, Vol. 10, Iss. 4, 2001-09 ,pp. : 159-165

Elsevier

Access to resources Recommend Favorite

How Should We Treat Hypertension and Dyslipidemia in Patients with Prediabetes?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3773-3787

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Use of Rituximab in Patients with HIV Related Lymphoma and Multicentric Castleman's Disease

By  

Current Drug Delivery, Vol. 9, Iss. 1, 2012-01 ,pp. : 41-51

Bentham Science Publishers

Access to resources Recommend Favorite